Navigation Links
Gentris Corporation Opens New Genomic Biomarker Laboratory in China
Date:11/20/2013

MORRISVILLE, N.C., Nov. 20, 2013 /PRNewswire/ -- Gentris® Corporation (www.gentris.com), a global leader in the application of genomic biomarkers to clinical studies, announced today that it has opened a new genomic biomarker testing and biorepository services laboratory in Shanghai, China. Gentris Shanghai will provide GCLP-compliant testing and biobanking services for global pharmaceutical clients under international standards.

(Logo: http://photos.prnewswire.com/prnh/20130916/CL80771LOGO )

"The launch of Gentris Shanghai is a tremendous milestone for our company," said Dr. Amelia Wall Warner, Gentris President and CEO. "Gentris is creating an international quality, global organization capable of providing genomic biomarker testing and biobanking services for clinical trials. In addition to commercial services, we are building collaborations with top Chinese research organizations, universities, and companies to accelerate drug development and innovation."

Gentris Shanghai will solve a critical need for pharmacogenomic (PGx) testing and clinical sample storage under international standards in China. Drug developers increasingly conduct large, integrated clinical trials that span the globe. China has been a primary focus in recent years due to a rapidly growing economy and tremendous investments in pharmaceutical, biotechnology, and innovation infrastructure. Gentris Shanghai provides the necessary services and expertise to conduct PGx-enabled clinical trials in China and accelerate drug development globally.

"This is an exciting time for Gentris as we expand into China, which is now the third largest pharmaceutical market in the world," said Dr. Tong Zhou, Gentris Shanghai General Manager. "Our sponsors are increasingly incorporating China into global clinical trials and we are working with them to meet a critical need for harmonized, international standards for biobanking and genomic biomarker testing."

Initial services will include biobanking and nucleic acid prep. Genotyping and gene expression services will launch in 2014 with phased implementation based on market demand.

Gentris Shanghai is also working closely with government organizations, medical researchers, and hospitals to create translational research, education, and training collaborations focused on genomic biomarker testing and biobanking that will drive innovation in drug development and patient care. For example, Gentris, the Shanghai Institutes of Preventative Medicine, and an independent research institute are conducting a study to collect and analyze biospecimens from tuberculosis patients in China to evaluate drug-induced liver injury and potential biomarkers. By working with Gentris and its collaborators, industry sponsors will be able to gain access to unique clinical samples, patient populations, and new technology in China.

Related Links: www.gentris.com

About Gentris Corporation:
Founded in 2001, Gentris is located in Research Triangle Park, NC, where it provides pharmacogenomics and biorepository support for all phases of clinical studies and genomic biomarker programs. The company works with academic and industry leaders to translate innovations in pharmacogenomics into safer, more effective medicines, which can lead to accelerated drug development and improvement in patient care globally. In the past year, Gentris has significantly expanded its facility and onsite biorepository to meet the increased needs of biopharma clients, while maintaining a preeminent quality system.

About Gentris Shanghai
Gentris Shanghai builds on over 10 years of genomic biomarker testing and biorepository services in the USA. The company was created from the ground up to ensure the highest quality services performed under international regulatory standards. The mission of Gentris Shanghai is to enable globally-integrated pharmacogenomics drug development studies in China. In addition to commercial services, Gentris Shanghai has built relationships with leading research organizations, hospitals, universities, and government agencies in China in order to facilitate collaborations and partnerships that can accelerate innovation and improve patient care globally.


'/>"/>
SOURCE Gentris Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gentris Corporation Partners with the Shanghai Institutes of Preventative Medicine
2. Gentris Corporation Launches New Pharmacogenomics Services
3. Gentris Corporation Announces Collaboration to Study Blood Stability
4. Gentris Corporation Expands Headquarters, Biorepository
5. Gentris Integrated Biorepository Receives Accreditation From The College of American Pathologists
6. Gentris Corporation Launches Next Generation Human Transcriptome Array
7. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
8. CVS Caremark Corporation to Hold First Quarter 2012 Conference Call
9. Richard Wolf Medical Instruments Corporation: 40 Years of Innovation
10. Haemonetics Signs Definitive Agreement to Acquire Pall Corporations Blood Collection, Filtration and Processing Product Lines For $551 Million
11. Luminex Corporation Reports First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/15/2017)... Aug. 15, 2017   Mostyn Law and Gulf Coast ... Houston, Texas . The Mostyn Law family has ... years. That is why Mostyn Law is partnering with ... to show its appreciation. Blood supplies are running low. ... short of hospital needs in August. That is why the blood ...
(Date:8/15/2017)... 15, 2017  AOTI Inc. announced today that its fully owned ... recently opened a New York City Office in Yonkers, ... unique Topical Wound Oxygen (TWO 2 ) homecare therapy. This new ... for Health Care (ACHC) under the company,s DMEPOS accreditation for Home/Durable ... Advanced ...
(Date:8/8/2017)... AVIV, Israel, Aug. 8, 2017  BioLineRx Ltd. (NASDAQ/TASE: ... immunology, today reports its financial results for the second ... achievements during the second quarter 2017 and to date: ... multiple clinical development programs for the Company,s lead project, ... 3 pivotal study with BL-8040 as novel stem cell ...
Breaking Medicine Technology:
(Date:8/18/2017)... (PRWEB) , ... ... ... For Immediate ... Polling Shows Young Women Seek Sex and Relationship Advice from ...
(Date:8/18/2017)... ... August 18, 2017 , ... Mediaplanet today announces the ... healthy lifestyles and highlighting the importance of proactive eye and ear health. The ... the latest innovations in hearing aid technology. , In this issue, the ...
(Date:8/18/2017)... WV (PRWEB) , ... August 18, 2017 , ... ... financial consulting services and asset protection assistance to communities in North-Central West Virginia, ... provide critical services to at-risk boys in the area. , The Chestnut Mountain ...
(Date:8/18/2017)... ... August 18, 2017 , ... Goss & Associates ... residential and commercial clients in the greater Houston region, is helping locally recognized ... the fight against cancer. , Founded by Tony and Amber Bender after losing ...
(Date:8/18/2017)... ... ... Overseer at The House of Yahweh in Abilene, Texas, has released a new publication this ... of the Savior whom the world calls “Mother Mary”. Yisrayl says when compared to what ... historical woman. , “The world bows, kisses the feet of, cries out to and ...
Breaking Medicine News(10 mins):